nad has been researched along with ximelagatran in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujioka, M; Gotoh, Y; Hirabayashi, A; Ishihara, T; Kamada, N; Nakabayashi, T; Sato, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
2 other study(ies) available for nad and ximelagatran
| Article | Year |
|---|---|
Characterization of in vitro biotransformation of the new oral anticoagulants, the factor VIIa inhibitors AS1927819-00 and AS1932804-00.
Topics: Animals; Anticoagulants; Azetidines; Benzylamines; Biotransformation; Factor VIIa; Hepatocytes; In Vitro Techniques; Intestinal Mucosa; Kinetics; Microsomes, Liver; Mitochondria, Liver; NAD; NADP; Phenoxyacetates; Prodrugs; Rats | 2013 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |